Sepsis is a time-critical medical emergency. Assessment and treatment of a patient with suspected sepsis are started urgently according to a locally approved clinical pathway, and their response to treatment is monitored and reviewed. The patient is reviewed by a clinician experienced in recognising and managing sepsis, and is escalated to a higher level of care when required.
The Acute Anaphylaxis Clinical Care Standard contains six quality statements describing the key components of care to improve the recognition of anaphylaxis, and the provision of appropriate treatment and follow-up care.
Planning for comprehensive care
Preventing delirium and managing cognitive impairment
A patient with known or suspected sepsis has a documented clinical handover at transitions of care. This includes the provisional sepsis diagnosis, comorbidities, and the management plan for medicines and medical conditions. This information is provided to the patient, their family and carer as appropriate.
Quality statement 5
A patient treated for anaphylaxis remains under clinical observation for at least four hours after their last dose of adrenaline, or overnight as appropriate according to the Australasian Society of Clinical Immunology and Allergy Acute Management of Anaphylaxis guidelines. Observation timeframes are determined based on assessment and risk appraisal after initial treatment.
Sepsis is a complex, multisystem disease requiring a multidisciplinary approach to treatment. A patient with sepsis has their treatment in hospital coordinated by a clinician with expertise in managing patients with sepsis.
The National Safety and Quality Health Service (NSQHS) Standards provide a nationally consistent statement of the level of care consumers can expect from health service organisations.
Predicting, preventing and managing self-harm and suicide
Organisational processes to support effective communication
This clinical care standard aims to improve the prevention of delirium in patients at risk – and the early diagnosis and treatment of patients with delirium.
Guidance for clinicians on the eight quality statements from the Low Back Pain Clinical Care Standard, as well as helpful resources.
The Commission is working in partnership with The George Institute for Global Health and Sepsis Australia to extend the National Sepsis Program. This program aims to improve the awareness, recognition and support for people at risk of or diagnosed with sepsis in Australia.
Healthcare services implement systems and processes to maximise safe, high-quality care and minimise clinical safety risks.
Quality statement 2
A patient with anaphylaxis, or suspected anaphylaxis, is administered adrenaline intramuscularly without delay, before any other treatment including asthma medicines. Corticosteroids and antihistamines are not first-line treatments for anaphylaxis.
Information for health service organisations to guide practice and monitor improvement using the clinical care standard, and resources to support implementation.
The Multi-Purpose Services Aged Care Module is designed to support eligible Multi-Purpose Services to improve aged care delivery. With a focus on quality and compliance, it's designed to simplify meeting NSQHS Standards while improving resident outcomes.
A patient with suspected sepsis has blood cultures taken immediately, ensuring that this does not delay the administration of appropriate antimicrobial therapy. When signs of infection-related organ dysfunction are present, appropriate antimicrobials are started within 60 minutes. Antimicrobial therapy is managed in line with the Antimicrobial Stewardship Clinical Care Standard, including a review within 48 hours from the first dose.
Collaboration and teamwork
The Commission has developed resources to assist health service organisations align their patient safety and quality improvement programs using the framework of the National Safety and Quality Health Service (NSQHS) Standards.